Submandibular gland cancer is a rare cancer that starts in one of the saliva glands under the jaw. Early symptoms of submandibular gland cancer can include a firm lump below the jaw, swelling, pain, numbness, or trouble swallowing, but some people have few symptoms at first. It can affect adults of any age, though it is more often diagnosed in middle-aged and older adults, and it usually lasts until it is treated. Not everyone will have the same experience. Treatment for submandibular gland cancer often involves surgery, and some people also need radiation therapy or other cancer treatment, while outlook and risk to life depend on the type, stage, and whether it has spread.
How many people live with Submandibular gland cancer?
Submandibular gland cancer is usually counted together with other salivary gland cancers, so separate living-with-it numbers are mostly estimates, not direct counts: about 170,000 people worldwide were alive within 5 years of a salivary gland cancer diagnosis (Global Cancer Observatory, 2022), and since about 10% to 15% of salivary gland cancers start in the submandibular gland (American Cancer Society, 2024), that suggests roughly 17,000 to 26,000 people worldwide living with submandibular gland cancer. In the United States, about 60,000 people were living after a salivary gland cancer diagnosis (NCI SEER, 2021), which suggests roughly 6,000 to 9,000 people living with submandibular gland cancer, again as an estimate rather than a direct count.
Overview
Submandibular gland cancerSymptoms
Submandibular gland cancer often causes a firm lump under the jaw. Early symptoms of submandibular gland cancer can also include swelling, pain, numbness, trouble swallowing, or weakness on one side of the face.
Outlook and prognosis
Submandibular gland cancer can often be treated successfully, especially when found early and still confined to the gland. Outlook depends on the tumor type, stage, and whether surgery removes it fully, so follow-up care is an important part of recovery.
Causes and risk factors
Submandibular gland cancer often has no clear cause. Risk may rise with prior head or neck radiation, older age, and certain workplace exposures such as nickel dust, silica dust, or asbestos. Smoking may also play a role.
Genetic influences
Genetics matter in submandibular gland cancer, but most cases are not clearly inherited. Gene changes in the tumor can help guide diagnosis and sometimes treatment, while inherited risk appears uncommon for many people with submandibular gland cancer.
Diagnosis
Submandibular gland cancer is usually diagnosed after a lump or swelling leads to an exam, imaging, and a biopsy. Diagnosis of submandibular gland cancer often relies on scans such as ultrasound, CT, or MRI, plus tissue testing.
Treatment and drugs
Submandibular gland cancer is often treated with surgery to remove the gland and nearby lymph nodes. Depending on the type and stage, radiation, chemotherapy, or targeted drugs may be added, especially if the cancer has spread or returned.
Symptoms
Submandibular gland cancer often shows up as a firm lump or swelling beneath the jaw, and it may or may not hurt. Because this gland sits near nerves and muscles used for chewing, swallowing, and facial movement, some people also notice pain, numbness, or weakness in the lower face. You might notice small changes at first, and the early symptoms of submandibular gland cancer can be easy to mistake for a blocked salivary gland, a dental problem, or an infection.
A new lump or swelling under the jaw is often the most noticeable symptom. It may feel firm, stay there instead of coming and going, and slowly get bigger over weeks or months.
Pain under the jaw, in the mouth, or near the ear can happen if the growth irritates nearby tissues. Some people feel soreness when chewing, touching the area, or turning the head.
Numbness, tingling, or a pins-and-needles feeling in the lower face can happen when submandibular gland cancer presses on a nearby nerve. This is less typical of a simple salivary gland blockage and deserves medical attention.
Some people with submandibular gland cancer notice weakness around the mouth or lower face. A smile may look uneven, or keeping food and liquid in the mouth may take more effort.
How people usually first notice Submandibular gland cancer?
People usually first notice submandibular gland cancer as a firm lump or swelling under the jaw, often near the angle of the lower jaw, that does not go away and may slowly grow over time. For many, it is painless at first, which is why it can be easy to ignore, but some people also notice numbness, weakness in part of the face, trouble swallowing, or pain that spreads to the ear or jaw. Because these changes can also happen with infections or noncancerous salivary gland problems, a persistent lump under the jaw is not automatically cancer, but it is a reason to get checked promptly.
Types of Submandibular gland cancer
Submandibular gland cancer can show up in a few different forms, based on the kind of cells the cancer starts from. These types of submandibular gland cancer can behave differently, so the symptoms and speed of growth are not always the same. Sometimes, symptoms cluster together in recognizable ways. Many people first notice a firm lump under the jaw, but some types are more likely to cause pain, numbness, or trouble with nearby nerves.
Mucoepidermoid carcinoma
This type often causes a lump under the jaw that may grow slowly or more quickly, depending on how aggressive it is. Some people have little discomfort at first, while others notice pain, swelling, or trouble chewing as it gets larger.
Adenoid cystic
This type is known for growing along nerves, so pain, tingling, or numbness can stand out more than with some other forms. The lump may seem small at first, but symptoms can feel out of proportion because nearby nerves are involved.
Adenocarcinoma
This is a broad group of cancers that usually presents as a firm mass in the submandibular gland. Symptoms may become noticeable faster if the tumor is more aggressive, with swelling, pain, or reduced movement in nearby tissues.
Acinic cell
This type is often slower growing and may start as a painless lump that is easy to overlook for a while. Not everyone will experience every type of symptom, but some may later notice pressure, tenderness, or fullness under the jaw.
Carcinoma ex pleomorphic adenoma
This cancer develops from a tumor that was once benign, so some people notice a long-standing lump that suddenly starts growing faster. Pain, firmness, or new nerve-related symptoms can be clues that the tumor has changed.
Can I slow down the onset of symptoms?
Probably not in any proven way: for submandibular gland cancer, which starts in a saliva-making gland under the jaw, there is no strong evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay when symptoms begin, although not smoking and limiting alcohol may help lower general cancer risk and support overall health. There is also no routine screening test that is known to prevent this cancer or reliably delay symptoms in people at average risk, so the most useful step is to get a new lump under the jaw, ongoing pain, numbness, or trouble swallowing checked early. This cannot guarantee prevention, but acting early can sometimes lead to earlier treatment and a better chance of controlling the disease.
What genetics can tell you about symptoms
Genetics can sometimes give clues about how submandibular gland cancer behaves, but they usually cannot predict exactly which symptoms someone will have day to day. Certain gene changes in the cancer may be linked with faster growth or a higher chance of spread, which can affect how early symptoms show up and how severe problems such as a lump under the jaw, pain, numbness, or trouble swallowing may become. Even so, symptoms vary a lot from one person to another, so genetics is only one part of the picture alongside the tumor type, size, and location.
Causes and risk factors
Most submandibular gland cancer starts when cells in the gland develop DNA changes over time. Risk rises with older age and with past radiation treatment to the head or neck. Rarely, inherited gene changes or certain family cancer syndromes can raise the chance of submandibular gland cancer. Workplace exposure to some industrial dusts or chemicals may also play a role, and researchers are still learning how these pieces fit together. Smoking may raise risk for some salivary gland cancers, but the link is not as clear as it is for many other head and neck cancers.
What are the most common causes or risk factors?
For many people with submandibular gland cancer, there is no clear single cause, but the risk goes up with older age and with past radiation treatment or heavy radiation exposure to the head and neck. Some long-term workplace exposures, such as breathing in certain dusts or industrial chemicals, may also raise the risk. Most cases are not strongly linked to an inherited gene change, so they usually happen because changes build up in the gland’s cells over time rather than because the condition runs in the family.
Environmental and biological risk factors
Submandibular gland cancer is uncommon, so most people with one of these risk factors will never develop it. Some risks are carried inside the body, others come from the world around us. The main risk factors for submandibular gland cancer are older age, past radiation exposure, and certain workplace exposures, while many cases happen without a clear reason.
Most cases of submandibular gland cancer are found in older adults, often after age 50. Risk rises over time because cells have had longer to collect damage.
Radiation aimed at the head or neck, usually as treatment for another cancer, can raise the chance of a later salivary gland cancer. This added risk may not appear until many years after the exposure.
Long-term contact with certain industrial dusts, fumes, and chemicals has been linked to salivary gland cancers. Examples include nickel alloy dust, silica dust, asbestos, and some exposures in rubber or woodworking jobs. These links are uncommon and usually involve repeated exposure over time.
Some salivary gland cancers are diagnosed slightly more often in men than in women. This is a broad pattern and does not mean sex alone can predict who will develop submandibular gland cancer.
Genetic risk factors
Most submandibular gland cancer cases are not clearly inherited, and a strong family pattern is uncommon. When people ask about genetic risk factors for submandibular gland cancer, the main points are rare inherited cancer syndromes, family history, and DNA changes found only in the tumor. Carrying a genetic change doesn’t guarantee the condition will appear. The exact genes involved can differ by tumor subtype.
Family history: Having a close relative with salivary gland cancer may slightly raise risk, but this pattern is uncommon. Most people with submandibular gland cancer do not have a known family history of the disease.
Inherited syndromes: Rare inherited cancer syndromes can increase the chance of salivary gland cancers, including cancers in the submandibular gland. Doctors may think about genetic counseling when several close relatives have related cancers, cancer at a young age, or more than one primary cancer in the same person.
Tumor-only changes: Many genetic changes linked to submandibular gland cancer develop only in the gland cells that turn cancerous. These changes are usually acquired rather than inherited, so they are not typically passed down through families.
Gene fusions: Some subtypes are driven by gene joins, also called fusions, that switch growth signals on. These patterns differ by subtype, which helps explain why two people with submandibular gland cancer can have different lab results and may need different treatment plans.
Lifestyle risk factors
Submandibular gland cancer has fewer clearly proven lifestyle links than many other head and neck cancers. Among the possible lifestyle risk factors for submandibular gland cancer, tobacco use is the best supported, while evidence for other habits is weaker or less consistent. Diet, body weight, physical activity, and alcohol may still influence overall cancer risk and general health, even when their direct effect on this specific cancer is not firmly established.
Smoking and other tobacco use may increase the risk of salivary gland cancers, including cancers that arise in the submandibular gland. The longer and heavier the exposure, the greater the likely harm to cells in the head and neck region.
Alcohol is not a well-established direct cause of submandibular gland cancer, but heavy long-term use may add to general head and neck cancer risk. It can also worsen nutrition and overall health, which may reduce the body’s ability to recover from illness and treatment.
A diet low in fruits, vegetables, and other nutrient-rich foods may reduce intake of antioxidants and other compounds that help protect cells from damage. Although the direct link is not strong, poor diet is one of the ways how lifestyle affects submandibular gland cancer risk in a broader cancer-health context.
Overweight and obesity can promote chronic inflammation and hormonal changes that may support cancer development in some tissues. A specific link to submandibular gland cancer is not firmly proven, but maintaining a healthy weight supports overall cancer prevention.
Risk prevention
Submandibular gland cancer is uncommon, and many people who develop it do not have a clear preventable cause. That means there is no guaranteed way to prevent submandibular gland cancer, but some steps may lower risk and support earlier diagnosis. Prevention is about lowering risk, not eliminating it completely. Because this cancer can be linked to radiation and a few lifestyle or workplace risks, prevention focuses on avoiding known exposures and getting new symptoms checked promptly.
Smoking and other tobacco use can expose the salivary glands to cancer-causing chemicals. If you use tobacco, quitting may help lower the risk of submandibular gland cancer and other head and neck cancers.
Avoid unnecessary radiation to the head and neck when safe alternatives are available. If radiation treatment is medically needed, your care team works to balance benefit and risk carefully.
Some jobs involve dusts, fumes, or industrial chemicals that may raise salivary gland cancer risk over time. Using recommended masks, ventilation, and safety practices can help reduce long-term exposure.
Heavy alcohol use is more clearly linked to several head and neck cancers than to submandibular gland cancer itself, but limiting it is still a sensible risk-reduction step. For many, this can mean smaller amounts, fewer drinking days, or both.
Can you prevent Submandibular gland cancer?
There is no sure way to prevent submandibular gland cancer, a rare cancer in one of the saliva-making glands under the jaw, because its exact cause is often not clear. The one risk factor doctors know best is radiation to the head and neck, so avoiding unnecessary radiation exposure may help, but many people who develop this cancer have no clear risk factors at all.
Transmission
Submandibular gland cancer is not infectious, so it cannot be passed from one person to another through kissing, coughing, sex, blood, or sharing food, drinks, or utensils. If someone in your family has it, being around them does not put you at risk of catching Submandibular gland cancer.
In most cases, Submandibular gland cancer is also not inherited directly from a parent. Rarely, an inherited tendency to certain cancers can raise risk, but the genetic transmission of Submandibular gland cancer is not the usual explanation, and most cases happen because changes build up in cells over time.
When to test your genes
For submandibular gland cancer, routine inherited gene testing is not usually recommended for early detection. Genetic testing may be worth discussing if you have a strong family history of salivary gland or related cancers, or features of a hereditary cancer syndrome. Tumor testing can help guide treatment in advanced, recurrent, or metastatic disease.
Diagnosis
Submandibular gland cancer is often found after a new lump or swelling appears under the jaw, sometimes along with pain, numbness, or trouble swallowing. Doctors usually diagnose it by combining an exam with imaging and a tissue sample, because several noncancerous salivary gland problems can look similar at first. It’s natural to worry when symptoms don’t have a clear explanation, but the diagnosis of submandibular gland cancer is usually built step by step to make sure the cause is clear.
Doctors ask about when the lump started, how quickly it has changed, and whether there is pain, facial weakness, trouble swallowing, or unexplained weight loss. A detailed family and health history can help identify other possible causes and guide the next tests.
The doctor feels the area under the jaw and inside the mouth to check the size, firmness, and movement of the gland or lump. They also look for enlarged lymph nodes in the neck and signs that nearby nerves may be affected.
Ultrasound, CT, or MRI can show the size of the mass and whether it has grown into nearby tissues. These scans also help doctors look for suspicious lymph nodes and plan the safest place to take a sample.
A fine-needle aspiration or core needle biopsy removes a small sample from the lump for lab testing. This is often the key step in how submandibular gland cancer is diagnosed, because it can show whether the growth is cancer and sometimes which type it is.
How is Submandibular gland cancer diagnosed?
Submandibular gland cancer is usually diagnosed after a doctor asks about symptoms, feels the lump under the jaw, and orders scans such as an ultrasound, CT scan, or MRI to see the gland and nearby tissues more clearly. The diagnosis is usually confirmed by taking a small sample of cells or tissue from the lump, often with a thin needle, and checking it under a microscope to see if cancer is present and what type it is. Doctors may also do more imaging to find out whether it has spread, which helps guide treatment.
Stages of Submandibular gland cancer
Submandibular gland cancer is usually described in stages from 1 to 4, based on how large the tumor is and whether it has spread to nearby lymph nodes or other parts of the body. Early stages are often more limited, while later stages mean the cancer is more advanced locally or has spread farther. Often the process begins when you notice changes in daily life, such as a firm lump under the jaw, swelling that does not go away, or trouble swallowing, which can be early symptoms of submandibular gland cancer.
Stage 1
The tumor is small and stays within the submandibular salivary gland. It has not spread to nearby lymph nodes or distant organs.
Stage 2
The tumor is larger than in stage 1 but is still mainly limited to the gland area. It still has not spread to lymph nodes or distant parts of the body.
Stage 3
Submandibular gland cancer may be larger, may have grown into nearby tissues, or may have spread to a nearby lymph node. This stage can still vary quite a bit from one person to another.
Stage 4
The cancer is more advanced and may involve deeper nearby structures, several lymph nodes, or distant organs such as the lungs. Stage 4 is often divided further because some cases are locally advanced while others have spread farther.
Outlook and prognosis
Outlook for submandibular gland cancer varies widely and depends mainly on the tumor type, stage at diagnosis, grade, and whether it can be completely removed with surgery. People with small, localized, low-grade tumors generally have a favorable prognosis, while high-grade cancers, spread to lymph nodes, perineural invasion, or distant metastases are linked to a higher risk of recurrence and worse survival. In general, survival for submandibular gland cancer is often less favorable than for parotid gland cancers because a higher proportion are malignant and biologically aggressive. Even after successful treatment, some salivary gland cancers can recur years later, so long-term follow-up is important. Mortality risk is highest in advanced-stage or metastatic disease, whereas early-stage disease treated effectively can be compatible with long-term survival.
Long-term effects
For many people, the long-term effects of submandibular gland cancer are shaped by both the cancer itself and the treatment used to control it. Some people do very well after treatment, while others live with lasting changes in the mouth, jaw, face, or neck. Thinking about the long-term effects helps set expectations for recovery and follow-up over time. These effects can vary a lot depending on the tumor stage, whether nerves were involved, and whether surgery, radiation, or both were needed.
Damage to the nearby salivary glands can leave the mouth much drier than before. This can make eating, speaking, and sleeping less comfortable, and it can raise the risk of tooth decay and mouth infections.
Surgery or radiation can lead to lasting trouble chewing or swallowing, especially with dry or tough foods. Many living with submandibular gland cancer notice meals take longer, and some may need softer foods for the long term.
Scarring in the floor of the mouth, jaw, or neck can make speech feel less clear and movement less easy. Some people also develop tightness that makes turning the head or opening the mouth harder.
If the cancer or treatment affects nearby nerves, there may be long-term weakness, numbness, or pain in parts of the face, tongue, or neck. In some cases, this can change facial movement or sensation in a way that lasts.
How is it to live with Submandibular gland cancer?
Living with submandibular gland cancer can affect some of the routines most people barely think about, including eating, speaking, swallowing, and turning the head comfortably, especially during treatment or recovery from surgery. Many people with this cancer also find that fatigue, pain, dry mouth, or worry about test results and follow-up visits can shape daily life in quiet but persistent ways, although the exact impact varies with the tumor’s size, stage, and treatment plan. For family and close friends, this can mean helping with appointments, meals, communication, and emotional support, but with good medical care, symptom management, and practical support, many people are able to regain stability and adapt to a new rhythm of daily life.
Treatment and drugs
Treatment for submandibular gland cancer often starts with surgery to remove the tumor and, in some cases, nearby lymph nodes if there is concern the cancer has spread. Depending on the stage and the tumor type, radiation therapy may be used after surgery to lower the chance of the cancer coming back, or sometimes instead of surgery when an operation is not a good option. If submandibular gland cancer is advanced or has spread, drug treatment such as chemotherapy, targeted therapy, or immunotherapy may be considered, although these are not needed for everyone. Treatment plans often combine several approaches. Not every treatment works the same way for every person, so your care team will tailor care to the cancer’s features, your overall health, and how treatment may affect speaking, swallowing, saliva, and day-to-day comfort.
Can you cure Submandibular gland cancer?
Sometimes, yes—submandibular gland cancer, a cancer in one of the saliva-making glands under the jaw, can sometimes be cured, especially if it is found early and removed completely. Treatment usually involves surgery, and some people also need radiation; these treatments aim to get rid of the cancer or lower the chance that it comes back. If the cancer has spread or cannot be fully removed, treatment may still help control it, slow it down, and ease symptoms.
Non-drug treatment
For many living with submandibular gland cancer, treatment often centers on procedures and supportive care rather than medicines alone. The main goals are to remove or control the tumor, protect breathing, speech, and swallowing, and help with recovery afterward. For many, treatment begins not at the pharmacy, but with surgery and other local therapies tailored to the stage and exact location of the cancer. Because early symptoms of submandibular gland cancer can look like a painless lump or swelling under the jaw, treatment plans can vary depending on how far the cancer has spread.
Surgery is usually the main non-drug treatment for submandibular gland cancer. It often removes the affected gland and may also take out nearby tissue or lymph nodes if there is concern the cancer has spread.
Radiation uses high-energy beams to target cancer cells in the area under the jaw and nearby tissues. It may be used after surgery to lower the chance of the cancer coming back, or sometimes instead of surgery if an operation is not possible.
If scans or exam findings suggest cancer may have reached lymph nodes, surgeons may remove nodes in the neck. This can help treat disease that has spread locally and gives clearer staging information for the next steps.
Some people need reconstructive procedures after tumor removal, especially if surgery affects nearby soft tissue, bone, or nerves. These repairs aim to preserve appearance and support everyday functions like speaking, chewing, and swallowing.
Your genes may have an impact on how drugs work for you
For most people with submandibular gland cancer, treatment is mainly surgery and radiation, so inherited gene differences do not affect care as often as they do in some other cancers. When the cancer has spread, comes back, or cannot be removed, some medicines may be used, and gene differences can matter in two main ways: they can change how your body breaks down a drug, which can affect side effects, and changes inside the cancer itself can sometimes help show whether a targeted treatment is more likely to work. This kind of drug-and-gene matching is sometimes called pharmacogenomics, but it is not a routine part of care for every person with this cancer.
Pharmacological treatments
Medicines for submandibular gland cancer are usually considered when the cancer has spread, come back, or cannot be fully treated with surgery or radiation alone. The exact drug plan depends a lot on the tumor type and whether testing shows a target such as HER2, androgen receptor, or an NTRK gene fusion. Not everyone responds to the same medication in the same way. For many living with submandibular gland cancer, treatment for advanced submandibular gland cancer may involve chemotherapy, targeted therapy, hormone-based treatment, or immunotherapy.
Cisplatin or carboplatin are common chemotherapy drugs used for salivary gland cancers, including submandibular gland cancer. They are often paired with another drug when doctors need treatment that works through the whole body.
Paclitaxel or docetaxel may be combined with platinum drugs to help slow tumor growth and ease symptoms. These combinations are more often used for recurrent, inoperable, or metastatic disease.
Fluorouracil, cyclophosphamide, and doxorubicin are sometimes used in combination regimens for certain salivary gland cancers. These drugs are not right for everyone, so the choice depends on overall health, prior treatment, and tumor behavior.
Trastuzumab may help if the cancer tests positive for HER2, which is seen in some aggressive salivary gland tumors. It is often given with chemotherapy rather than used alone.
Genetic influences
When submandibular gland cancer happens, many people quickly wonder what it might mean for their children, brothers, sisters, or parents. It’s natural to ask whether family history plays a role. In most cases, submandibular gland cancer is not clearly inherited, and the DNA changes that drive the cancer seem to develop in the gland cells during life rather than being passed down through a family. Still, a small number of people with submandibular gland cancer may have an inherited tendency to cancer, especially if several relatives have had related cancers or if the cancer appears at a younger age than expected. This is why questions about family history and the genetic risk factors for submandibular gland cancer sometimes come up during care. If that history is strong, doctors may suggest genetic counseling or testing to see whether an inherited cancer syndrome could be involved.
Is Submandibular gland cancer genetic?
Genetics matter in submandibular gland cancer, but most cases are not clearly inherited. Gene changes in the tumor can help guide diagnosis and sometimes treatment, while inherited risk appears uncommon for many people with submandibular gland cancer.
Having a genetic risk is not necessarily a diagnosis
Genetic differences are a normal part of human biology and are common throughout the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. For many genes, having a variant connected to a condition suggests a possible link rather than a clear diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people living with submandibular gland cancer, the drugs used are chosen partly by the tumor’s genetic makeup, not just where the cancer started. Some subtypes carry changes such as HER2 amplification or an NTRK gene fusion, and those findings can open the door to targeted therapy for submandibular gland cancer rather than relying only on standard chemotherapy. Beyond trial and error, genetics offers another way to match treatment more closely to the cancer, especially if it has spread or come back after initial care. Not every submandibular gland cancer has a change that can be targeted, so surgery and radiation often remain the main treatments, with chemotherapy, immunotherapy, or both considered in some advanced cases. Inherited genes can also affect how your body handles certain medicines, but for this cancer, tumor testing usually has a bigger role than personal pharmacogenetic testing. Because submandibular gland cancer is rare and includes several tumor types, doctors often use the pathology results and genetic findings together when deciding whether a targeted drug or a clinical trial may make sense.
Interactions with other conditions
Submandibular gland cancer can affect more than the gland itself, especially if it grows into nearby tissues or makes eating, swallowing, or speaking harder. People with submandibular gland cancer may already be dealing with dental problems, dry mouth, or infections in the mouth and throat, and these can become more troublesome during treatment. Doctors call it a comorbidity when two conditions occur together. For example, diabetes, poor nutrition, or immune system problems can slow healing after surgery or raise the risk of infection, while heart or lung disease may make anesthesia, radiation, or chemotherapy harder to tolerate. In more advanced cases, early symptoms of submandibular gland cancer can overlap with salivary gland infections or swollen lymph nodes from other illnesses, which sometimes delays diagnosis. If other cancers have been present before, especially in the head and neck area, your care team may look more closely at whether the new problem is separate or related, because that can change treatment planning.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Submandibular gland cancer?
A lump or swelling under the jaw can be caused by a blocked saliva duct from a stone, a salivary gland infection, swollen lymph nodes from a throat or tooth infection, or a noncancerous growth in the salivary gland. A cyst or another head and neck cancer can also cause similar signs, especially if there is pain, numbness, or trouble swallowing. Because these problems can look alike, a new or growing lump under the jaw needs a medical check.
History
A lump under the jaw can be easy to dismiss at first, especially if it is painless and slowly growing. For some people living with submandibular gland cancer, that quiet beginning is part of why the condition was difficult to recognize in the past. Before modern imaging and laboratory testing, doctors often grouped growths in the salivary glands together, and it was not always clear which were harmless and which were cancer.
Earlier medical descriptions focused mostly on what could be seen or felt during an exam, such as swelling near the lower jaw, trouble swallowing, or pain spreading toward the ear. Because the submandibular glands sit deep under the jaw and close to nerves and other tissues, early surgery could be challenging, and doctors had fewer ways to tell how far a tumor had spread before an operation. Over time, careful study of tissue under the microscope helped specialists separate different kinds of salivary gland cancers and understand that submandibular gland cancer was one small but important part of that larger group.
In recent decades, awareness has grown as scans, pathology testing, and more standardized cancer classification have improved diagnosis. This has helped doctors identify submandibular gland cancer earlier and more accurately, including cases that might once have been mistaken for a benign salivary gland lump or a swollen lymph node. These advances also made it easier to connect the early symptoms of submandibular gland cancer, such as a firm lump, numbness, or weakness in part of the face, with the need for prompt evaluation.
Treatment has changed as knowledge has expanded. Surgery has long been the main treatment, but modern care is more planned and precise, often involving head and neck surgeons, imaging specialists, pathologists, and cancer doctors working together. Researchers later identified genetic changes in some salivary gland cancers, which improved understanding of how these tumors develop, though this history is still being refined. For many, this can mean a clearer diagnosis, better treatment planning, and a more informed conversation about what to expect.